Tazobactam
Back to searchMolecule Structure
Scientific Name
Tazobactam
Description of the Drug
Tazobactam is a beta lactamase inhibitor administered with antibiotics such as piperacillin and ceftolozane to prevent their degradation, resulting in increased efficacy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01606
http://www.drugbank.ca/drugs/DB01606
Brand Name(s)
Not Available
Company Owner(s)
Wytells Pharma Private Ltd, Wockhardt Bio Ag, Fresenius Kabi Usa Llc, Steriscience Pte Ltd, Qilu Pharmaceutical Co Ltd, Astral Steritech Pvt Ltd, Sandoz Inc, Sagent Pharmaceuticals Inc, Hospira Inc, Istituto Biochimico Italiano Spa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial beta-lactamase TEM | SINGLE PROTEIN | INHIBITOR | CHEMBL2364670 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL122302 | |
| PharmGKB | PA164764504 | |
| Human Metabolome Database | HMDB0015544 | |
| DrugBank | DB01606 | |
| PubChem: Thomson Pharma | 14751709 | 16012340 |
| PubChem | 123630 | |
| Mcule | MCULE-7574505159 | |
| LINCS | LSM-5323 | |
| Nikkaji | J246.119F | |
| BindingDB | 50053173 | |
| EPA CompTox Dashboard | DTXSID8023634 | |
| DrugCentral | 2572 | |
| Brenda | 1226 | |
| ChemicalBook | CB7473784 | |
| Guide to Pharmacology | 10789 | |
| rxnorm | TAZOBACTAM | TAZOBACTAM SODIUM |
| KEGG Ligand | C07771 | |
| ChEBI | 9421 | |
| ZINC | ZINC000003787060 |
